Back in April 2020, AstraZeneca was hailed as a frontrunner in the race to get an effective vaccine to market. A year later, after a series of trial pauses, communication blunders, and PR problems, the vaccine is on the cusp of FDA approval.

By all accounts, the company succeeded in making a safe, effective vaccine. So why has there been so much confusion about its rollout?

Guest:

Peter Aldhous, science reporter at Buzzfeed News

Host

Lizzie O’Leary

Hosted on Acast. See acast.com/privacy for more information.

REBEL News Roundup 4.28.22